Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
1,3-Bis(4-bromophenyl)-5-phenyl-2,4-imidazolidinedione is a central cannabinoid (CB1) receptor antagonist and inverse agonist. It may be a potential therapeutic agent for treating obesity and drug dependence.
您的位置：
